Long-Term Assets: The sum of all assets classified as non-current.
Lantern Pharma Inc. (LTRN) had Long-Term Assets of $0.17M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.33M |
|
-- |
|
-- |
|
$3.41M |
|
$-3.41M |
|
$0.08M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.41M |
|
$-3.40M |
|
11.25M |
|
11.25M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$7.06M |
|
$0.03M |
|
|
Long-Term Assets |
$0.17M |
$7.22M |
|
$3.78M |
|
-- |
|
-- |
|
$3.78M |
|
$3.45M |
|
$3.45M |
|
$3.45M |
|
11.26M |
|
| Cash Flow Statement Financials | |
$-3.77M |
|
$4.25M |
|
-- |
|
$4.42M |
|
$4.92M |
|
$0.49M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-96.62% |
|
-96.62% |
|
-46.09% |
|
-96.62% |
|
$0.31 |
|
$-0.34 |
|
$-0.34 |
|